TUMOR IMMUNOLOGYMCKHANN CF; YARLOTT MA JR.1975; CA(CANCER J. CLINICIANS); U.S.A.; DA. 1975; VOL. 25; NO 4; PP. 187-197; BIBL. 16REF.Article

H-2 RESTRICTION OF THE T CELL RESPONSE TO CHEMICALLY INDUCED TUMORS: EVIDENCE FROM F₁->PARENT CHIMERASLANNIN DR; YU S; MCKHANN CF et al.1982; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1982; VOL. 128; NO 1; PP. 263-268; BIBL. 37 REF.Article

TUMOR SPECIFIC IMMUNE RESPONSIVENESS OF THE TUMOR BEARING HOST.BURK MW; YU S; MCKHANN CF et al.1976; ISRAEL J. MED. SCI.; ISRAEL; DA. 1976; VOL. 12; NO 4-5; PP. 360-368; BIBL. 13 REF.Article

SOLUBLE SUPPRESSOR FACTOR FROM THE SPLEENS OF TUMOR-BEARING MICESUBRAMANIAN C; YU S; MCKHANN CF et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 7; PP. 1996-2002; BIBL. 20 REF.Article

ADJUVANT IMMUNOTHERAPY OF MALIGNANT MELANOMAARANHA GV; MCKHANN CF; GRACE TB et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 4; PP. 1297-1303; BIBL. 18 REF.Article

THE VALUE OF PREOPERATIVE SCREENING PROCEDURES IN STAGE I AND II MALIGNANT MELANOMAARANHA GV; SIMMONS RL; GUNNARSSON A et al.1979; J. SURG. ONCOL.; USA; DA. 1979; VOL. 11; NO 1; PP. 1-6; BIBL. 16 REF.Article

A MICROASSAY FOR HUMORAL CYTOTOXICITY DEMONSTRATING SUBLETHAL EFFECTS OF ANTIBODY = MICRO-ESSAI DE LA CYTOTOXICITE HUMORALE MONTRANT LES EFFETS SUBLETLAUX DE L'ANTICORPSCLEVELAND PH; MCKHANN CF; JOHNSON K et al.1974; INTERNATION. J. CANCER; SWITZ.; DA. 1974; VOL. 14; NO 3; PP. 417-426; ABS. FR.; BIBL. 28 REF.Article

ADHERENT CELLS IN TUMOR IMMUNITY.BURK MW; BURK KR; YU S et al.1977; CELL. IMMUNOL.; U.S.A.; DA. 1977; VOL. 30; NO 1; PP. 43-53; BIBL. 11 REF.Article

IMMUNOTHERAPY OF MELANOMA WITH BCG : TWO FATALITIES FOLLOWING INTRALESIONAL INJECTIONMCKHANN CF; HENDRICKSON CG; SPITLER LE et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 35; NO 2; PP. 514-520; BIBL. 30REF.Article